Session Pages will be available 1 hour before the start time.

Start With FIRST-LINE BESREMi Pen for Patients With PV Requiring Cytoreductive Therapy: From Clinical Results to Real-World Practice will begin in:

Date
Tuesday, August 25, 2026

Time
12:00 PM (EDT)

Description

Learn about the role of BESREMi in the long-term management of polycythemia vera, with insights from Dr Beth Faiman on clinical trial data, disease control, and practical administration considerations.

This is a non-CME event. By registering for this program, you consent to share your registration information with the program's sponsor.